Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pycnodysostosis is a genetic lysosomal disease characterized by short stature, increased density of the bones (osteosclerosis/osteopetrosis), and brittle bones. Other features may include underdevelopment of the tips of the fingers with absent or small nails, an abnormal collarbone (clavicle), distinctive facial features including a large head with a small face and chin, underdeveloped facial bones, a high forehead, and dental abnormalities.Pycnodysostosis is an autosomal recessive condition caused by mutations in the gene that codes the enzyme cathepsin K (CTSK) on chromosome 1q21. The diagnosis of pycnodysostosis is based on physical features and X-ray findings. Molecular genetic testing is available. Treatment should address the symptoms found in each patient and may include orthopedic monitoring, treatment of fractures, appropriate dental care, and craniofacial surgery.
Features include: Carious teeth, Spondylolisthesis, Narrow palate, and Sideways curvature of the spine (scoliosis) and 19 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 4 | Sideways curvature of the spine (scoliosis), Osteolytic defects of the distal phalanges of the hand, Increased bone density (increased bone mineral density) |
CTSK encodes cathepsin K (329 aa). Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. Highest expression in Cervix Ectocervix (669.9 TPM) and Cervix Endocervix (642.5 TPM).
Pycnodysostosis is caused by mutations in the CTSK gene on chromosome 1.
The CTSK protein participates in Fibrillin-1 degradation by MMP3, CTSK, CTSL2, CTSL bind CTSL inhibitors, and MMP3, CTSK, CTSL2 pathways.
CTSK is classified as a druggable target (Druggable Genome, Enzyme, External Side Of Plasma Membrane, and Protease categories) with score 23.2.
Formal diagnostic criteria for pycnodysostosis have not been established, however the radiographic features of acroosteolysis, osteosclerosis, and loss of the normal angle of the jaw are almost pathognomonic.
Pycnodysostosis should be suspected in probands with the following clinical, radiographic, and laboratory findings.
Clinical findings
Source: GeneReviews — "Pycnodysostosis"
No approved treatments are currently available for pycnodysostosis. The disease remains an area of unmet medical need.
There are no published treatment or surveillance guidelines for pycnodysostosis or standard guidelines on the best method or surgical intervention for fracture treatment in this condition. Management should emphasize multidisciplinary care and a considered approach to surgical intervention when appropriate. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with pycnodysostosis, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Pycnodysostosis
Table 6. Recommended Surveillance for Individuals with Pycnodysostosis
System/Concern |
|---|
No clinical trials have been registered for pycnodysostosis.
20 publications have been identified in PubMed for pycnodysostosis. Research spans Case Report / Case Series (70%), Review / Meta-Analysis (15%), and Other (5%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 70% |
Data assembled from 8 of 12 sources · Last updated Sep 18, 2026, 3:55 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Head and neck |
1 |
Narrow palate |
Arms and legs | 1 | Osteolytic defects of the distal phalanges of the hand |
Growth and development | 1 | Short stature |
Skin | 1 | Ridged nail |
Pycnodysostosis is characterized by short stature, typical facial appearance (small jaw with obtuse mandibular angle and convex nasal ridge), osteosclerosis with increased bone fragility, acroosteolysis of the distal phalanges, delayed closure of the cranial sutures, and dysplasia of the clavicle. In affected individuals, the facial features become more prominent with age, likely due to progressive acroosteolysis of the facial bones, but can usually be appreciated from early childhood, particularly the small jaw and convex nasal ridge . A comprehensive review of previously published reports identified 159 individuals including 59 unrelated families with confirmed homozygous or compound heterozygous pathogenic variants in CTSK.
Source: GeneReviews — "Pycnodysostosis"
No clinically relevant genotype-phenotype correlations for CTSK have been identified.
Source: GeneReviews — "Pycnodysostosis"
It is critical to distinguish pycnodysostosis from other primary sclerosing conditions of bone characterized by osteopetrosis, since early hematopoietic stem cell transplantation may be a therapeutic option in some forms of osteopetrosis, whereas it would be of no benefit in individuals with pycnodysostosis, which rarely presents with bone marrow insufficiency .
Table 3.
Disorders Characterized by Osteopetrosis in the Differential Diagnosis of Pycnodysostosis
Features of DifferentialDisorder Overlappingw/Pycnodysostosis | Gene(s) | Differential Disorder | MOI | Features of DIfferential Disorder Not Observed in Pycnodysostosis
Source: GeneReviews — "Pycnodysostosis"
Genetic testing for CTSK is available. Testing is considered confirmatory for diagnosis.
System/Concern | Evaluation | Comment |
|---|---|---|
Musculoskeletal | Complete radiographic skeletal survey incl lateral spine radiographs | Consider skull CT. |
Respiratory | Polysomnography | For all affected persons as early as practicable |
Dental | Baseline dental eval | — |
Neurologic | Consider MRI. | If neurologic symptoms or concern re Chiari malformation |
Eyes | Baseline ophthalmologic exam | Genetic |
counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of pycnodysostosis to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with Pycnodysostosis Manifestation/Concern | Treatment | Considerations/Other Growth hormone deficiency/ Short stature |
Scoliosis | Mgmt per orthopedist | — |
Craniofacial | Craniofacial/neurosurgical mgmt as required for cleft palate, craniosynostosis, maxillary mandibular hypoplasia | May incl distraction osteogenesis of mandible /or maxilla Obstructive sleep apnea |
Requirement for anesthesia | Consultation w/expert anesthetist prior to any planned surgery | May be at risk for difficult intubation Dental |
Vision concerns | Standard mgmt per ophthalmologist | OT = occupational therapist Surveillance Table 6. |
Recommended Surveillance for Individuals with Pycnodysostosis System/Concern | Evaluation | Frequency |
General health | Physical exam | Annually or as indicated Musculoskeletal |
Respiratory | Polysomnography | Every 2 yrs |
Dental | Eval w/specialist dentist | Annually Vision |
Obesity | Weight assessment ± dietitian review | Annually or as indicated Psychological |
Source: GeneReviews — "Pycnodysostosis"
In the case of general anesthesia, consideration should be given to the possibility of difficult intubation prior to scheduling anesthesia. Bisphosphonate therapy is contraindicated due to underlying osteoclast dysfunction in pycnodysostosis.
Source: GeneReviews — "Pycnodysostosis"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Pycnodysostosis"
View trials for pycnodysostosis
Evaluation
Frequency |
|---|
General health | Physical exam | Annually or as indicated Musculoskeletal |
Respiratory | Polysomnography | Every 2 yrs |
Dental | Eval w/specialist dentist | Annually Vision |
Obesity | Weight assessment ± dietitian review | Annually or as indicated Psychological |
Source: GeneReviews — "Pycnodysostosis"
Estimated prevalence: 1-9 in 1,000,000 (Rare).
3 |
15% |
Other research | 1 | 5% |
Laboratory research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Finnie E (2026). [PMID: 41852695](https://pubmed.ncbi.nlm.nih.gov/41852695/). *Case Rep Womens Health*. [Case Report / Case Series]
Chaves Junior CM (2026). [PMID: 42115820](https://pubmed.ncbi.nlm.nih.gov/42115820/). *Cleft Palate Craniofac J*. [Basic Science / Preclinical]
Kesineni MK (2026). [PMID: 42004881](https://pubmed.ncbi.nlm.nih.gov/42004881/). *Clin Case Rep*. [Case Report / Case Series]
Baptista F (2025). [PMID: 41189620](https://pubmed.ncbi.nlm.nih.gov/41189620/). *Front Endocrinol (Lausanne)*. [Other]
Bovis M (2025). [PMID: 40523612](https://pubmed.ncbi.nlm.nih.gov/40523612/). *J Stomatol Oral Maxillofac Surg*. [Review / Meta-Analysis]
Tyagi R (2025). [PMID: 40485967](https://pubmed.ncbi.nlm.nih.gov/40485967/). *J Clin Exp Dent*. [Case Report / Case Series]
Alsagheir A (2025). [PMID: 40313484](https://pubmed.ncbi.nlm.nih.gov/40313484/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Bouhamdi A (2025). [PMID: 41450906](https://pubmed.ncbi.nlm.nih.gov/41450906/). *Respir Med Case Rep*. [Case Report / Case Series]
Crespo-Reinoso PA (2025). [PMID: 41726200](https://pubmed.ncbi.nlm.nih.gov/41726200/). *Ann Maxillofac Surg*. [Case Report / Case Series]
Canarslan-Demir K (2025). [PMID: 40544148](https://pubmed.ncbi.nlm.nih.gov/40544148/). *Diving Hyperb Med*. [Case Report / Case Series]
AI-curated news mentioning pycnodysostosis
Updated Sep 12, 2026
A case study highlights the use of ALIGNOGRAM(1.0) analysis to assess bone microarchitecture and predict fractures in a young female with pycnodysostosis. This research could pave the way for novel fracture prediction technologies in rare bone disorders.
A case report highlights a pediatric patient with pycnodysostosis who developed severe obstructive sleep apnea. This study contributes to the understanding of complications associated with this rare disease.